BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS)

CUSIP: G11217117

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / CLASS A ORD SHS
Total 13F shares
19,286,449
Share change
+806,129
Total reported value
$192,795,000
Price per share
$10.00
Number of holders
65
Value change
+$8,222,625
Number of buys
25
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) as of Q2 2022

As of 30 Jun 2022, BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,286,449 shares. The largest 10 holders included Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Linden Advisors LP, GOLDMAN SACHS GROUP INC, Polar Asset Management Partners Inc., D. E. Shaw & Co., Inc., CANTOR FITZGERALD, L. P., MMCAP International Inc. SPC, and AQR Arbitrage LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.